rs28936376
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 9P and 0B. PM1PM2PP3_StrongPP5
The NM_000098.3(CPT2):c.1657G>A(p.Asp553Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,796 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000098.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CPT2 | NM_000098.3 | c.1657G>A | p.Asp553Asn | missense_variant | Exon 5 of 5 | ENST00000371486.4 | NP_000089.1 | |
CPT2 | NM_001330589.2 | c.1588G>A | p.Asp530Asn | missense_variant | Exon 5 of 5 | NP_001317518.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000796 AC: 2AN: 251166Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135802
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461796Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 727196
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Carnitine palmitoyl transferase II deficiency, myopathic form Pathogenic:1
- -
Carnitine palmitoyltransferase II deficiency Pathogenic:1
Variant summary: CPT2 c.1657G>A (p.Asp553Asn) results in a conservative amino acid change located in the Choline/carnitine acyltransferase domain (IPR039551) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 8e-06 in 251166 control chromosomes. c.1657G>A has been reported in the literature in at least 1 individual affected with Carnitine Palmitoyltransferase II Deficiency (example, Verderio_1995, Corti_2008). At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect in vitro results in a drastic reduction in enzyme activity and steady state protein levels (example, Verderio_1995). The following publications have been ascertained in the context of this evaluation (PMID: 17936304, 7711730). ClinVar contains an entry for this variant (Variation ID: 8955). Based on the evidence outlined above, the variant was classified as likely pathogenic. -
Carnitine palmitoyl transferase II deficiency, severe infantile form Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at